MCOLN2 Promotes Autophagy to Drive Adriamycin Resistance in Breast Cancer
High expression of MCOLN2 drives Adriamycin resistance in breast cancer by destabilizing mTOR to promote autophagy, according to laboratory and ...
High expression of MCOLN2 drives Adriamycin resistance in breast cancer by destabilizing mTOR to promote autophagy, according to laboratory and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.